NNOX
Nano-X Imaging Ltd.
NNOX lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
NNOX Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
NNOX's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
NNOX PE Valuation
NNOX has no meaningful PE right now: it lost money over the past year.
NNOX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect NNOX's losses to shrink, with revenue growing.
NNOX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.70 | -$0.80 |
| Q1 2026 | -$1.14 | -$0.24 |
| Q4 2025 | -$1.15 | -$0.25 |
| Q3 2025 | -$0.88 | -$0.03 |
| Q2 2025 | -$0.90 | +$0.09 |
| Q1 2025 | -$0.90 | +$0.17 |
| Q4 2024 | -$0.90 | +$0.17 |
| Q3 2024 | -$0.85 | +$0.90 |
NNOX is still losing money, but less than at its worst: $1.70 per share over the past year, against $2.03 at its worst in late 2022.
NNOX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.2M | +37% |
| Q1 2026 | $4.3M | +53% |
| Q4 2025 | $3.7M | +24% |
| Q3 2025 | $3.4M | +14% |
| Q2 2025 | $3M | +13% |
| Q1 2025 | $2.8M | +10% |
| Q4 2024 | $3M | +25% |
| Q3 2024 | $3M | +22% |
NNOX's revenue has grown year over year for 19 quarters in a row: $4M last quarter, up 37% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1335% | -858 points |
| Q1 2026 | -343% | +157 points |
| Q4 2025 | -481% | +18 points |
| Q3 2025 | -413% | +54 points |
| Q2 2025 | -477% | +61 points |
| Q1 2025 | -501% | +12 points |
| Q4 2024 | -499% | +54 points |
| Q3 2024 | -466% | +421 points |
NNOX's operating margin was −1335% last quarter, down 858 points from the same quarter a year ago, near the bottom of its range since 2021.
NNOX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$12.6M | -$2.2M |
| Q1 2026 | -$15.7M | -$4.9M |
| Q4 2025 | -$12.5M | -$922.8K |
| Q3 2025 | -$12.5M | -$3.6M |
| Q2 2025 | -$10.4M | -$1M |
| Q1 2025 | -$10.9M | -$1.3M |
| Q4 2024 | -$11.6M | +$890.5K |
| Q3 2024 | -$8.9M | +$3.5M |
NNOX has burned cash in almost every quarter: −$53M over the past year, against −$42M the year before.
NNOX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +312K shares |
| 1 year | +9.4% | +6M shares |
| 3 years | +26% | +14.6M shares |
| 5 years | +46% | +22.2M shares |
| Available history | +105% | +35.8M shares |
NNOX has 70M diluted shares, up 9.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NNOX hasn't bought back shares in the past year.
NNOX Net Leverage
NNOX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NNOX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.9 | Oversold |
| Stochastic | 7.0 | Oversold |
NNOX's weekly RSI is 27 (oversold) and its Stochastic is 7 (oversold).
NNOX PE vs Healthcare Sector
NNOX has no meaningful PE right now: it lost money over the past year.
NNOX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.44 | 27% below |
| 20 week MA | $0.75 | 57% below |
| 50 week MA | $1.73 | 82% below |
| 100 week MA | $3.50 | 91% below |
| 200 week MA | $6.06 | 95% below |
NNOX is in a downtrend: it's below all five of its weekly moving averages, and 95% below its 200-week average.
NNOX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $49.6 | $52.5 | +5.7% |
| 2021 | $52.5 | $17.9 | -66% |
| 2022 | $17.9 | $8.02 | -55% |
| 2023 | $8.02 | $6.37 | -21% |
| 2024 | $6.37 | $7.59 | +19% |
| 2025 | $7.59 | $2.86 | -62% |
| 2026 YTD | $2.86 | $0.32 | -89% |
NNOX has finished lower in four of the last six years. It's down 89% so far in 2026.